If you accidentally took a double dose of Ozempic (semaglutide), do not panic
The widespread interest in GLP-1 receptor agonists for weight loss, particularly amid drug shortages, has renewed clinical and regulatory attention to their safety profile, yet the clinical profile of acute exposures remains poorly understood, wrote first author Jordan Miller, a researcher with The University of Texas at San Antonio, and colleagues
Patients with BMI 30 or greater often have the strongest coverage eligibility
Integration with microfluidic systems, Bayesian optimization, and high-content phenotypic screening allows iterative refinement through active learning loops, effectively bridging bench-scale innovation and translational readiness [465]
Except oral semaglutide, GLP-1 RAs are administered subcutaneously, particularly those with proven CV benefits